KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash & Equivalents: 2019-2024

Historic Cash & Equivalents for Hims & Hers Health (HIMS) over the last 6 years, with Dec 2024 value amounting to $220.6 million.

  • Hims & Hers Health's Cash & Equivalents rose 108.91% to $345.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $345.8 million, marking a year-over-year increase of 108.91%. This contributed to the annual value of $220.6 million for FY2024, which is 128.20% up from last year.
  • Hims & Hers Health's Cash & Equivalents amounted to $220.6 million in FY2024, which was up 128.20% from $96.7 million recorded in FY2023.
  • Hims & Hers Health's Cash & Equivalents' 5-year high stood at $220.6 million during FY2024, with a 5-year trough of $27.3 million in FY2020.
  • Moreover, its 3-year median value for Cash & Equivalents was $96.7 million (2023), whereas its average is $121.3 million.
  • Per our database at Business Quant, Hims & Hers Health's Cash & Equivalents spiked by 1,710.45% in 2020 and then slumped by 34.84% in 2022.
  • Over the past 5 years, Hims & Hers Health's Cash & Equivalents (Yearly) stood at $27.3 million in 2020, then soared by 162.52% to $71.8 million in 2021, then slumped by 34.84% to $46.8 million in 2022, then soared by 106.67% to $96.7 million in 2023, then soared by 128.20% to $220.6 million in 2024.